Liposorber

Call Directions Website

Liposorber LIPOSORBER therapy removes LDL-C and Lp(a) from the blood and is indicated for FH and FSGS patients.

We are excited to announce that DFCon 2026 will be our first time exhibiting at this premier meeting dedicated to diabet...
10/16/2026

We are excited to announce that DFCon 2026 will be our first time exhibiting at this premier meeting dedicated to diabetic foot care and limb preservation!
The LIPOSORBER team will be headed to Anaheim, CA, on October 22-24, where we'll have the opportunity to connect with podiatrists, vascular surgeons, endocrinologists, wound care specialists, and other healthcare professionals committed to improving outcomes for patients at risk of limb loss.
As first-time exhibitors, we're looking forward to engaging with the limb preservation community, sharing insights, building new relationships, and learning from the experts advancing care in this important field.
If you'll be attending, be sure to stop by and meet the LIPOSORBER team. We can't wait to connect with you in Anaheim!

đź“ŤJW Marriott Anaheim Resort | Anaheim, CA
🗓️ October 22-24, 2026


Apheresis isn't only used for cholesterol disorders.LIPOSORBER is also FDA-authorized under a Humanitarian Device Exempt...
10/14/2026

Apheresis isn't only used for cholesterol disorders.

LIPOSORBER is also FDA-authorized under a Humanitarian Device Exemption for eligible patients with primary Focal Segmental Glomerulosclerosis (FSGS), a rare kidney disease that can lead to serious kidney damage when standard treatments fail.

Awareness can help patients discover additional treatment options and connect with knowledgeable care teams sooner.

For eligible patients with drug-resistant or recurrent FSGS, studies have reported approximately 50% complete or partial remission following treatment with Liposorber as part of the overall management approach.

Learn about how LIPOSORBER can benefit patients with primary FSGS: liposorber.com/kidney-disease/liposorber-for-fsgs

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

Reference: Muso E, et al. Immediate therapeutic efficacy of LDL apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study. Clin Exp Nephrol. 2015;19(3):379-386.

đź’™ Happy National Physician Assistant Week!This National Physician Assistant Week, we celebrate the incredible impact Phy...
10/07/2026

đź’™ Happy National Physician Assistant Week!

This National Physician Assistant Week, we celebrate the incredible impact Physician Assistants have on patient care.

From educating patients and coordinating treatment plans to helping manage complex cardiovascular conditions, PAs are at the forefront of improving outcomes and enhancing patient experiences.

Thank you for your unwavering commitment to the patients and families you serve. The Liposorber team is proud to honor and celebrate you this week and beyond.

What happens when healthy lifestyle choices and maximum medications still aren't enough to manage severe Familial Hyperc...
09/24/2026

What happens when healthy lifestyle choices and maximum medications still aren't enough to manage severe Familial Hypercholesterolemia (FH)? 🧬

FH Awareness Day is an opportunity to identify patients who may benefit from additional treatment options. For high-risk individuals with severe FH, dangerously elevated LDL-C or Lipoprotein(a) [Lp(a)] can persist despite best efforts.

That is where advanced cardiovascular treatment options come in. The LIPOSORBER® System performs targeted lipoprotein apheresis, selectively removing atherogenic lipoproteins directly from the bloodstream.

If you or a loved one is struggling to control severe FH, talk to your specialist about whether lipoprotein apheresis is right for your treatment plan.

đź”— For Indications for Use and Important Safety Information, please visit: liposorber.com/liposorber-safety-info



09/24/2026

September Updates: A Month of Awareness, Education & Patient Inspiration

In this issue of our monthly Newsletter, we highlight Apheresis and FH Awareness Day, plus we share Anthony's inspirational FH story

❌ Myth: Lipoprotein apheresis treatment is too expensive and difficult to access.✅ Fact: Kaneka offers a dedicated reimb...
09/23/2026

❌ Myth: Lipoprotein apheresis treatment is too expensive and difficult to access.
âś… Fact: Kaneka offers a dedicated reimbursement team that works with treatment sites on coding, coverage, and operational support to help streamline access to LIPOSORBER treatment.

If you've been told that advanced treatment options are out of reach, know that support is available. Reimbursement advocates can help guide patients through the insurance process and connect them with resources to access LIPOSORBER treatment.

Talk to your healthcare team about available coverage and support resources.

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

Did you know? High cholesterol isn't always caused by lifestyle – it can be genetic. Familial Hypercholesterolemia (FH) ...
09/20/2026

Did you know? High cholesterol isn't always caused by lifestyle – it can be genetic. Familial Hypercholesterolemia (FH) is an inherited condition that can cause extremely high cholesterol from birth.

For certain high-risk FH patients who are unable to achieve adequate LDL-C and/or Lp(a) control despite maximum tolerated therapy, LIPOSORBER® may be a treatment option.

Talk with your healthcare provider if:
âś… You have been clinically diagnosed with FH
âś… Your LDL-C and/or Lp(a) remains severely elevated despite diet & medication
âś… You've experienced cardiovascular disease or events despite controlled lipid management

Early diagnosis and intervention can make a difference.

đź”— For Indications for Use and important safety information, visit: liposorber.com/liposorber-safety-info

September 15th is Apheresis Awareness Day, and we're recognizing patients, nurses, physicians, and treatment teams who r...
09/15/2026

September 15th is Apheresis Awareness Day, and we're recognizing patients, nurses, physicians, and treatment teams who rely on apheresis therapies to manage serious conditions.

Did you know that LIPOSORBER® is the only FDA-approved lipoprotein apheresis system in the United States?

When diet, lifestyle changes, and medications are not enough, LIPOSORBER can help eligible patients remove LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] directly from the bloodstream.

Together, we're raising awareness of treatment options that provide hope when standard therapies fall short.

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

💙 As we approach Apheresis Awareness Day, we're honoring the incredible teams behind every LIPOSORBER® treatment. From p...
09/15/2026

💙 As we approach Apheresis Awareness Day, we're honoring the incredible teams behind every LIPOSORBER® treatment. From physicians and nurses to coordinators, vascular access specialists, and support staff - your commitment helps transform complex treatment journeys into compassionate patient care. Apheresis care is a team effort.

Thank you for educating, monitoring, supporting, and advocating for patients every day. We appreciate all that you do!

For LIPOSORBER Indications for Use and other safety information, please visit:
https://liposorber.com/liposorber-safety-info

September 15th is Apheresis Awareness Day, and we're recognizing patients, nurses, physicians, and treatment teams who r...
09/14/2026

September 15th is Apheresis Awareness Day, and we're recognizing patients, nurses, physicians, and treatment teams who rely on apheresis therapies to manage serious
conditions.

Did you know that LIPOSORBER® is the only FDA-approved lipoprotein apheresis system in the United States? *

When diet, lifestyle changes, and medications are not enough, LIPOSORBER can help eligible patients remove LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] directly from the bloodstream.

Together, we're raising awareness of treatment options that provide hope when standard therapies fall short.

*LIPOSORBER is FDA approved for the treatment of certain high-risk patients who are clinically diagnosed with familial hypercholesterolemia (FH). It is also FDA-authorized as a Humanitarian Use Device for the treatment of patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).

For full LIPOSORBER Indications for Use and other safety information, please visit:
https://liposorber.com/liposorber-safety-info

Address

623 5th Avenue 27th FL
New York, NY
10022

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

(800)5263522

Website

Alerts

Be the first to know and let us send you an email when Liposorber posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category